Pertz, Milena http://orcid.org/0000-0002-4275-2492
Schlömer, Sabine
Seidel, Clemens
Hentschel, Bettina
Löffler, Markus
Schackert, Gabriele
Krex, Dietmar
Juratli, Tareq
Tonn, Joerg Christian
Schnell, Oliver
Vatter, Hartmut
Simon, Matthias
Westphal, Manfred
Martens, Tobias
Sabel, Michael
Bendszus, Martin
Dörner, Nils
Wick, Antje
Fliessbach, Klaus
Hoppe, Christian
Klingner, Marcel
Felsberg, Jörg
Reifenberger, Guido
Gramatzki, Dorothee
Weller, Michael
Schlegel, Uwe
,
Funding for this research was provided by:
German Glioma Network (Grant No.: 107940, 109459 (108074a))
German Cancer Aid (Reference No.: 107940/109459, 110586)
Ruhr-Universität Bochum
Article History
Received: 10 July 2023
Accepted: 9 August 2023
First Online: 30 August 2023
Declarations
:
: Michael Sabel has served as Consultant for Novocure, Integra /Codman; Klaus Fliessbach and Christian Hoppe received license fees from Eisai Inc. (Frankfurt/Main, Germany); Uwe Schlegel received speaker’s honoraria from medac, Novartis, GSK and med update.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethics committees and the ethics committee of the leading institution (Tübingen, Germany, Registration No.: 353/2003 V).
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.